Contact UsSitemapSearch
FacultyCommercial OpportunitiesPeer Institutions
Johns Hopkins University Technology Transfer
About Tech Transfer
Access the JHTT Data System
Initiate an Agreement
Search Available Technologies
Resources


News and Events

8/15/08
GBTC names JHTT's Aris Melissaratos as Baltimore's Extraordinary Technology Advocate Award Winner for 2008

7/31/08
Johns Hopkins Biotechnology 2008 Conference: "Neuroscience Investor's Conference: Investing in Brain Research" to be held Thursday, September 18, 2008

6/23/08
JHTT takes part in the BIO Conference in San Diego, CA

5/30/08
JHTT takes part in the ASCO Conference in Chicago, IL

View Full List >

JHU ALLIANCE


The Johns Hopkins Alliance for Science & Technology Development is a 28-member committee charged with evaluating the commercial viability of selected research projects at Johns Hopkins University School of Medicine. The JHU Alliance will then evaluate marketing opportunities and provide assistance with the identification of financing to enable the commercialization of the worthy discoveries.

The JHU Alliance consists of pharmaceutical and biotech executives, medical device designers and manufacturers, representatives from the diagnostics world, and venture capitalists, as well as angel investors.

The JHU Alliance's charter is to evaluate research projects within the School of Medicine and determine the commercial strength of each project and assign a JHU Alliance member to champion its development and marketability. The group will also become the university's conduit toward creating awareness among industry leaders and business entrepreneurs.

This alliance among business leaders and university researchers has been made possible under the provisions of the Bayh-Dole Act, which encourages the utilization of inventions produced under federal funding and promotes the participation of universities and small businesses in the development and commercialization process. It also permits exclusive licensing with transfer of an invention to the marketplace.

For more information please contact:
Helen Montag

Corporate Relations Manager
hmontag@jhmi.edu
410-516-4976 or 410-371-8776

The Johns Hopkins University
Alliance for Science and Technology Development
Industry Membership (“Alliance”)

Aris Melissaratos, Chairman
Senior Advisor to the President for Enterprise Development
Johns Hopkins University

Liza Bailey
Private Investor/Retired Credit Suisse Investment Banking Manager Director

James J. Barry, PhD
VP Corporate Research & Advanced Technology Development
--Boston Scientific

David S. Block, MD, MBA
Founder and CEO
--Ruxton Pharmaceuticals, Inc.

David S. Bredt, MD, PhD
Vice President, Integrative Biology
--Lilly Research Laboratories

James Campbell, MD
Scientific Advisor
--Interwest Partners

C. Thomas Caskey, MD, FACP
Director & CEO
--Brown Foundation Institute of Molecular Medicine
Executive Vice President of Molecular Medicine and Genetics
--The University of Texas Health Science Center at Houston

Mr. Joseph A. Ciffolillo
(retired medical device executive)
     
Kenneth Fasman, PhD
Vice President and Chief Technology Officer
--Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Robert Garland, MD
Partner
--New Enterprise Associates

Philip Goelet, PhD
Director
--Red Abbey

Ms. Elizabeth Good
Director, Strategic Investments
--University of Maryland at Baltimore

Mr. Steve Gorlin
Principal
--Gorlin Companies

Mr. David W. Hockenbrocht, Chairman
Founding Chairman of the Alliance
(Retired President & CEO of Sparton Corporation)

Leroy E. Hood, MD, PhD
President
--Institute for Systems Biology

Mr. Edwin M. Kania, Jr.
Managing Partner and Chairman
--Flagship Ventures

Mr. Robert S. King
FIVE PRIME ADVISORS, LLC

Chris Kroeger, MD, MBA
Principal
--Aurora Funds, Inc.

Joseph Lawler, MD, PhD
Oz-Ziff Capital Management Group

Robert D. Mashal, MD
President & CEO
--Alinea Pharmaceuticals

Mr. Troy Moore
Chief Technology Officer
--Open Biosystems

Mr. Richard Newman
Vice President, Advanced Solutions, Emeritus
--Welch Allyn, Inc.

James Niedel, MD, PhD
Managing Director
--New Leaf Venture Partners, LLC

Stephen N. Oesterle, MD
Sr. Vice President for Medicine and Technology
--Medtronic, Inc.

John Perchorowicz, PhD
Vice President, Business Development
--RCT BioVentures/Research Corporation Technologies, Inc.

James A. Poulos, III
Vice President, Technology Transfer and Commercialization
--Maryland Technology Development Corp. (TEDCO)

Major General Garrison Rapmund, MD, U.S. Army, Retired
Sr. Fellow, Krasnow Institute for Advanced Study, George Mason University

Bruce C. Robertson, PhD
Managing Director
--H.I.G. Ventures

Mark C. Rogers, MD, MBA
Chairman and CEO
--Bradmer Pharmaceuticals

Christopher Shen, MD, MBA
Partner
--Essex Woodlands Health Ventures

Irving Sherman, MD
(retired neurosurgeon)

Ms. Amita Shukla
Principal
--NEA

Craig R. Smith, MD
Williston Consulting, LLC
(retired Chairman, President, & CEO, Guilford Pharmaceuticals)

Joseph M. Smith, MD, PhD, FACC
(formerly with Guidant Corporation)
Guidant Corporation

Jason Sydow, PhD
Principal
--Questmark Partners

Copyright 2007.  All Rights ReservedLegal/PrivacyDesign Credits
Untitled Document